Essential Thrombocythemia Market Set for Significant Growth Driven by Emerging Therapies, Rising Prevalence, and Expanding Pipeline Through 2036
According to DelveInsight’s analysis, the Essential Thrombocythemia market size was found to be ~USD 430 million in the leading markets – the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan – in 2025. The United States